MiRdetect
Latest round
- Seed
Last raised
- May 2019
Total raised
- Undisclosed
Investors
- 2
About MiRdetect
Founded in 2016 and headquartered in Bremen, Germany, MiRdetect GmbH specializes in molecular diagnostics aimed at cancer detection. The company has engaged in at least one investment deal, with the most recent deal occurring on May 2, 2019.MiRdetect GmbH specializes in the development, production, and distribution of highly sensitive and reliable molecular biological tests designed for the early detection and diagnosis of cancer. The company’s core offerings enable the detection of minute quantities of nucleic acids with exceptional precision, utilizing a simple blood sample from patients. These diagnostic tests are characterized by their high sensitivity and specificity, positioning them to redefine standards in medical diagnostics.The revenue model for MiRdetect GmbH primarily revolves around B2B transactions with healthcare institutions and laboratories, which incorporate the company's diagnostic tests into their service offerings. The company employs a direct sales approach to establish partnerships with hospitals and clinics, ensuring that their proprietary tests, known for their reliability, are readily available for medical professionals and patients. Detailed pricing structures are implemented for each diagnostic test, reflecting their advanced technology and clinical value. The company is in the process of designing additional diagnostic tests, aiming for a launch within the next few years. Expansion plans include targeting the North American market to complement their existing European presence, aligning with the growing trend toward early cancer detection and personalized medicine.
Who invested in MiRdetect
2 investors across 1 round
See all investors in MiRdetect
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 2, 2019
Amount
Undisclosed
Investors
Questions about MiRdetect
Who invested in MiRdetect?
MiRdetect has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MiRdetect raised?
MiRdetect has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MiRdetect last raise money?
MiRdetect's most recent round on record is a Seed, in May 2019.
What does MiRdetect do?
Founded in 2016 and headquartered in Bremen, Germany, MiRdetect GmbH specializes in molecular diagnostics aimed at cancer detection.
Where is MiRdetect headquartered?
MiRdetect is headquartered in Bremen, Germany.
Which VCs invest in companies like MiRdetect?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at MiRdetect's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like MiRdetect? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.